Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.

BRCA mutations are encountered in almost 50% of young Israeli ovarian cancer patients; they are associated with serous tumors and high CA125 levels at diagnosis, but are not independently associated with recurrence or survival in this patient population.